WallStreetZenWallStreetZen

NASDAQ: SPRY
Ars Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Ars Pharmaceuticals revenue was $89.15M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $86.6M, up 4,086.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SPRY annual revenue was $89.1M, with 297,063.3% growth year-over-year.

SPRY past revenue growth

How has SPRY's revenue growth performed historically?

Company
297,063.33%
Industry
511.06%
Market
20.87%
SPRY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SPRY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SPRY's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SPRY revenue history

Current Revenue
$89.1M
Current Earnings
$8.0M
Current Profit Margin
9%

Be the first to know when SPRY announces revenue.

SPRY Revenue History By Year

SPRY Yearly RevenueSPRY RevenueSPRY ChangeSPRY Revenue Growth
2024-12-31$89.15M$89.12M+297,063.33%
2023-12-31$30.00k-$1.29M-97.72%
2022-12-31$1.32M-$4.19M-76.10%
2021-12-31$5.51MN/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Ars Pharmaceuticals Revenue FAQ

What was SPRY's revenue last quarter?

On Invalid Date, Ars Pharmaceuticals (NASDAQ: SPRY) reported Q4 2024 revenue of $86.58 million up Infinity% year over year. In the same quarter last year, Ars Pharmaceuticals's revenue was $0.00.

What was Ars Pharmaceuticals's revenue in 2024?

Ars Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $89.15 million, a 297,063.33% increase year over year.

How much does Ars Pharmaceuticals make in a day?

Based on Ars Pharmaceuticals annual revenue for the past five years, SPRY makes an average of $52,603.29 per day.

What was Ars Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Ars Pharmaceuticals's revenue has grown 297,063.33% year over year. This is 296,552.27 percentage points higher than the US Biotechnology industry revenue growth rate of 511.06%. Ars Pharmaceuticals's revenue in the past year totaled $89.15 million.

How much does Ars Pharmaceuticals make in a year?

Ars Pharmaceuticals's revenue by year for the past five years is:
  • Ars Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $89.15 million, a 297,063.33% increase year over year.
  • Ars Pharmaceuticals's annual revenue for Dec 31, 2023 was $30.00 thousand, a 97.72% decrease from 2022.
  • Ars Pharmaceuticals's annual revenue for 2022 was $1.32 million, a 76.1% decrease from 2021.
  • Ars Pharmaceuticals's annual revenue for 2021 was $5.51 million, a Infinity% increase from 2020.
  • Ars Pharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.